Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Employment test 11 - 50 employees
Company dna ernest gutmann yves plasseraud sas
operating since 1985
Headquarter in Paris and 2 offices
active in Legal Services and IP Consulting

Representative before the EPO

Company dna grosset fournier and demachy
no operation time available
2 offices
active in Legal Services

We have observed 19 EP applications Fabienne Paris has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 13, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13305499

Olfactory means useful in the diagnosis and treatment of mood depression

IPC classification:
A61B 5/16, A61B 5/00
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Fabienne Paris, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13305778

Methods for predicting rheumatoid arthritis treatment response

IPC classification:
G01N 33/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Cabinet Plasseraud
Agent:
Multiple attorneys, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
EXAMINATION IN PROGRESS
EP13800985

NOVEL CELL WALL DECONSTRUCTION ENZYMES OF SCYTALIDIUM THERMOPHILUM, MYRIOCOCCUM THERMOPHILUM, AND AUREOBASIDIUM PULLULANS, AND USES THEREOF

IPC classification:
A23L 1/305, A23K 1/165, A23K 1/00, A21D 13/00, A21D 8/04, D21C 9/00, D21C 5/00, D06M 16/00, C12P 7/06, C12N 15/55, C12N 15/53, C12N 15/52, C12N 15/37, C12N 15/36, C12N 9/58, C12N 9/24, C12N 9/16, C12N 9/14, C12N 9/02, C12N 9/00, C12N 1/21
Applicant:
Concordia University
Agent:
Multiple attorneys, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
GRANT OF PATENT INTENDED
EP13758976

BIODEGRADABLE DRUG DELIVERY FOR HYDROPHOBIC COMPOSITIONS

IPC classification:
A61K 47/34, A61K 38/13, A61K 31/57, A61K 31/565, A61K 31/445
Agent:
D Young & Co LLP
Agent:
Multiple attorneys, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
GRANT OF PATENT INTENDED
EP13306644

TAL effector means useful for partial or full deletion of DNA tandem repeats

IPC classification:
A61K 48/00, A61K 38/16, C12N 15/62, C12N 15/10, C12N 9/22, A61P 25/00, A61P 21/00, A61P 19/00
Agent:
Fabienne Paris, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12761807

PLAGUE VACCINE

IPC classification:
A61K 39/102, C12N 1/36
Applicant:
Institut Pasteur
Agent:
Multiple attorneys, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
The patent has been granted
EP15172430

INFLUENZA VACCINE, COMPOSITION, AND METHODS OF USE

IPC classification:
A61K 39/145, A61K 39/10, A61K 39/00, A61K 31/16, A61P 31/16
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
National University of Singapore
Agent:
Multiple attorneys, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14716816

OLFACTORY MEANS USEFUL IN THE DIAGNOSIS AND TREATMENT OF MOOD DEPRESSION

IPC classification:
A61B 5/00, A61B 5/16
Applicant:
Institut Pasteur
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Multiple attorneys, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
EXAMINATION REQUESTED
EP14307130

TXA2 inhibitor as stimulator or inducer of MHC Class I cross-presentation

IPC classification:
A61P 35/00, A61K 45/00
Agent:
Multiple attorneys, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP16155296

LIVE ATTENUATED BORDETELLA STRAINS AS A SINGLE DOSE VACCINE AGAINST WHOOPING COUGH

IPC classification:
A61K 39/00, A61K 39/02, A61K 39/10, C12N 1/36
Agent:
Multiple attorneys, Grosset-Fournier & Demachy
Agent:
Multiple attorneys, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
EXAMINATION REQUESTED
EP15305098

RNA virus attenuation by alteration of mutational robustness and sequence space

IPC classification:
A61K 39/00, A61K 39/12, C12N 7/00
Agent:
Multiple attorneys, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
APPLICATION PUBLISHED
EP14838781

TAL EFFECTOR MEANS USEFUL FOR PARTIAL OR FULL DELETION OF DNA TANDEM REPEATS

IPC classification:
A61K 48/00, A61K 38/16, A61P 19/00, A61P 21/00, A61P 25/00, C12N 15/62, C12N 15/10, C12N 9/22
Applicant:
Institut Pasteur
Agent:
Multiple attorneys, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
EXAMINATION IN PROGRESS
EP15726231

NADPH OXIDASE PROTEINS

IPC classification:
C12Q 1/26, C12N 9/02
Applicant:
Community Grenoble Alpes University (Communauté Université Grenoble-Alpes)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
IPSIDE Schmit-Chretien
Agent:
Multiple attorneys, Grosset-Fournier & Demachy
Status:
EXAMINATION REQUESTED
EP15802959

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS

IPC classification:
C12R 1/445, C12N 1/20, C07K 16/12, A61K 39/395
Agent:
Fabienne Paris, Grosset-Fournier & Demachy
Status:
EXAMINATION REQUESTED
EP16733102

CYCLIZED SULFAMOYLARYLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
A61P 31/20, A61K 31/407, C07D 513/20, C07D 515/20, C07D 291/08, C07D 515/04, C07D 513/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Fabienne Paris, Johnson & Johnson
Status:
Request for examination was made
EP17203628

PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/506, A61K 31/505, C07D 471/04, C07D 413/12, C07D 405/12, C07D 403/12, C07D 401/12, C07D 239/48
Agent:
Kristina Victoria Joy Cornish, Kilburn & Strode LLP
Agent:
Fabienne Paris, Johnson & Johnson
Status:
Request for examination was made
EP18156744

GLYOXAMIDE SUBSTITUTED PYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
A61P 31/00, A61K 31/40, C07D 207/34
Agent:
Fabienne Paris, Johnson & Johnson
Status:
Examination is in progress
EP17735472

DIHYDROPYRANOPYRIMIDINES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61P 37/04, A61K 31/505, C07D 491/052
Agent:
Kristina Victoria Joy Cornish, Kilburn & Strode LLP
Agent:
Fabienne Paris, Johnson & Johnson
Status:
Request for examination was made
EP17772270

MODIFIED OLIGONUCLEOTIDES AND METHODS OF USE

IPC classification:
C07H 21/02, A61K 31/7125, A61K 31/712, C12N 15/113
Agent:
Fabienne Paris, J&J Patent Law Department
Status:
Request for examination was made

Please Sign in to use this feature